Board Moves.

Avanos Medical (NYSE: AVNS)

Appoints Indrani Franchini to the Board of Directors. Ms. Franchini is the former Chief Leadership Officer at Alnylam Pharmaceuticals.

Boston Scientific (NYSE: BSX)

Appoints David Habiger to the Board of Directors. Mr. Habiger is the Chief Executive Officer at J.D. Power and Associates.

Edwards Lifesciences (NYSE: EW)

Appoints David Feinberg to the Board of Directors. Mr. Feinberg is the former Chief Executive Officer at Cerner Corporation

Hims & Hers Health (NYSE: HIMS)

Appoints Kåre Schultz to the Board of Directors. Mr. Schultz is the former Chief Financial Officer at Teva Pharmaceutical.

Lexeo Therapeutics (NASDAQ: LXEO)

Appoints Tim Van Hauwermeiren to the Board of Directors. Mr. Van Hauwermeiren is a Co-Founder and Chief Executive Officer at argenx SE.

Lexicon Pharmaceuticals (NASDAQ: LXRX)

Michael Exton named CEO and he is appointed to the Board of Directors. Mr. Exton is the former Head of Cardiometabolism Therapeutics at Novartis.

Maravai LifeSciences (NASDAQ: MRVI)

Appoints William Martin to the Board of Directors. Mr. Martin is the Chief Executive Officer at Maravai LifeSciences.

Moderna (NASDAQ: MRNA)

Appoints David Rubenstein to the Board of Directors. Mr. Rubenstein is the Co-Founder and Co-Chair of the Board at The Carlyle Group.

NewAmsterdam Pharma NV (NASDAQ: NAMS)

Appoints Wouter Joustra and Mark McKenna to the Board of Directors. Mr. Joustra is a General Partner at Forbion and Mr. McKenna is a Partner at Arch Venture.

Orchestra BioMed (NASDAQ: OBIO)

Appoints John Mack to the Board of Directors. Mr. Mack is the former Division President of Cardiac Surgery at Medtronic.

Pfizer (NYSE: PFE)

Appoints Cyrus Taraporevala to the Board of Directors. Mr. Taraporevala is the former Chief Executive Officer at State Street Global Advisors.

Procept BioRobotics (NASDAQ: PRCT)

Appoints Thomas Prescott to the Board of Directors. Mr. Prescott is the former Chief Executive Officer at Cardiac Pathways.

Scilex (NASDAQ: SCLX)

Appoints Annu Navani to the Board of Directors. Ms. Navani is the Founder and CEO at Comprehensive Spine & Sports Center and she is a Professor at Stanford University School of Medicine

Skye Bioscience (NASDAQ: SKYE)

Appoints Karen Smith to the Board of Directors. Ms. Smith is the former Senior Vice President.

SpringWorks Therapeutics (NASDAQ: SWTX)

Appoints Martin Mackayto the Board of Directors. Mr. Mackayto is the Co-Founder and Executive Chair of the Board at Rallybio.

Stereotaxis (NYSE: STXS)

Appoints Nachum Shamir to the Board of Directors. Mr. Shamir is the former Chair of the Board and Chief Executive Officer at Luminex.

Xeris Biopharma (NASDAQ: XERS)

John Shannon promoted to CEO and he is appointed to the Board of Directors.

‍

‍

Collegium Pharmaceutical (NASDAQ: COLL)

Neil McFarlane resigns from the Board of Directors. Mr. McFarlane is the Chief Executive Officer at Zevra Therapeutics.

Gyre Therapeutics (NASDAQ: GYRE)

Nassim Usman resigns from the Board of Directors. Mr. Usman is the Chief Executive Officer at Totus Medicines.

Harmony Biosciences (NASDAQ: HRMY)

Jack Bech Nielsen resigns from the Board of Directors. Mr. Bech is the Managing Partner at Vivo Capital.

INmune Bio (NASDAQ: INMB)

Edgardo Baracchini resigns from the Board of Directors. Mr. Baracchini is the former Chief Business Officer at Xencor.

OmniAb (NASDAQ: OABI)

Joshua Tamaroff resigns from the Board of Directors. Mr. Tamaroff is a former Partner at Avista Capital.

Perrigo (NYSE: PRGO)

Todd Penegor resigns from the Board of Directors. Mr. Penegor is the former Chief Executive Officer at Wendy’s.

Privia Health (NASDAQ: PRVA)

Bill Sullivan resigns from the Board of Directors. Mr. Sullivan is the Founder at Brighton Health Partners.

Renovaro (NASDAQ: RENB)

Leni Boeren resigns from the Board of Directors. Ms. Boeren is the Chief Executive Officer at Kempen Capital Management.

National HealthCare (NYSE: NHC)

Ernest Burgess retires from the Board of Directors. Mr. Burgess is the former SVP Operations at National HealthCare.